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Available online 22 November 2017The epidemiologic information demonstrates the importance of caring people with epilepsy (PWE). Indeed, the
impaired quality of life (QoL) and medication nonadherence rate among PWE have been reported. However, re-
ligiosity and religious coping could be potential factors for clinicians to foster appropriate intervention on epilep-
tic care. This study investigated twomodels to further understand the relationships between religiosity, religious
coping (including positive and negative coping), medication adherence, and QoL in an Iranian sample with epi-
lepsy. Eligible PWE (n = 760) completed the religiosity scale (Duke University Religion Index; DUREL) at base-
line; the religious coping scale (Brief Religious Coping Scale; Brief RCOPE) one month later; the medication
adherence scale (Medication Adherence Report Scale; MARS-5) two months later; and the QoL scale (Quality
of Life in Epilepsy; QOLIE-31) twelve months later. Their antiepileptic drug serum level was measured during
the period they completed theMARS. Through structural equation modeling (SEM), we found that religiosity di-
rectly correlated with negative religious coping and medication adherence, and indirectly correlated with med-
ication adherence through negative religious coping. Both positive and negative religious coping directly
correlated with medication adherence and QoL. Therefore, religiosity and religious coping may be determinants
of medication adherence and QoL in PWE; health professionals may consider asking PWE if religion is important
to them and how they use it to cope with their epilepsy.
© 2017 Elsevier Inc. All rights reserved.Keywords:
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Epilepsy is an important problem in developing countries because of
the high incidence (~10 to 19 per 10,000 person-year) [1] and the neg-
ative impact of epileptic symptoms on quality of life (QoL) [2,3]. A re-
cent review analyzed 45 articles [4] and concluded that Iran has a high
prevalence of epilepsy (5% in central Iran; 1% in northern Iran; 4% in
eastern Iran). As antiepileptic drugs (AEDs) have controlled symptoms
[5] and QoL has improved [6,7], medication adherence is a key factorpsy, PWE; Antiepileptic drugs,
ious Coping Scale, Brief RCOPE;
5; Quality of Life in Epilepsy,
ive ﬁt index, CFI; Tucker–Lewis
SEA; Standardized root mean
ealth Research Center (SDH),
vd, Qazvin 3419759811, Iran.in the lives of people with epilepsy (PWE). Unfortunately, the poor
adherence to medication is a problem among PWE: medication
nonadherence rates range between 30 and 50% [8–10]. Hence, improv-
ing medication adherence in this population should be a top priority.
In order to address medication adherence, we thought that religios-
ity and religious coping in Iran could be important determinants. Religi-
osity is a multidimensional concept, including personal religious beliefs
(intrinsic religiosity), individual involvement in public religious activi-
ties (organizational religiosity), and private religious practices such as
praying and reading religious texts (nonorganizational religiosity) [11,
12]. Moreover, the link between religiosity and epilepsy has been dem-
onstrated amongPWE(e.g.,Wise–Knut) [13]; indeed, approximately 4%
of PWE reported religious premonitory symptoms or auras [14]. An un-
derlying mechanism also has been proposed: religious cognition is re-
lated to speciﬁc brain regions and people with brain disorder
(e.g., PWE) may have neuropsychological processes that predispose
them to greater religiosity [15]. Although to our knowledge, no studies
have examined whether religiosity is positively related to medication
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tive relationship [16,17]. Therefore, we hypothesized that religiosity
may be positively associatedwithmedication adherence in PWE in Iran.
In addition to the direct relationship, religious coping could be ame-
diator in the relationship between religiosity and medication adher-
ence. Religious coping is different than coping in general. According to
the religious coping theory proposed by Pargament et al. [18], religious
coping involves ﬁnding meaning, gaining control, gaining comfort,
gaining intimacy with others and closeness to God, and achieving life
transformation through religious methods. More general forms of cop-
ing do not usually include such methods. Religious beliefs and activities
have been reported to be important strategies for copingwithmanydis-
eases including cardiovascular diseases [19]. A relationship between re-
ligious coping and medication adherence has been found: negative
religious coping was negatively related to self-reported medication ad-
herence in people with inﬂammatory bowel disease [20]. Thus, we hy-
pothesized that religiosity may affect medication adherence through
religious coping.
We assume that religiosity, spirituality, and mood interact with one
another. Pargament et al. [18] have deﬁned spirituality as the key func-
tion of religion, and Koenig et al. [21] indicate that spirituality may (or
maynot) lead to or arise from thedevelopment of religious rituals.More-
over, the relationship between religiosity and psychiatric symptomswas
found to be similar to, but not the same as the relationship between spir-
ituality and psychiatric symptoms [22]. Other studies have found that
mood is associated with religiosity/spirituality [23,24]. Therefore, we as-
sumed that religiosity, spirituality, and mood are three related factors,
while religiosity and spirituality are similar but different concepts.
Because better medication adherence is related to higher level of
QoL [25,26], we additionally postulated that religiosity and religious
coping may be indirectly correlated with QoL through medication ad-
herence. However, research is mixed with regard to support of this
proposition. Giovagnoli et al. [27] found a positive relationship between
religiosity and QoL, whereas Tedrus et al. [12] reported no relationship
between religiosity and QoL. Because mediated effects are usually
weak, some studies may detect such associations while others may
not. Hence, we considered using amediatedmodel to better understand
the relationship between religiosity, medication adherence, and QoL. As
for the religious coping, we hypothesized that it might also have a direct
association with QoL for PWE as demonstrated by Tedrus et al. [28].
We proposed two models to examine the relationships among reli-
giosity, religious coping, medication adherence, and QoL in an Iranian
sample of PWE. Speciﬁcally, Model 1 (Fig. 1) hypothesized that religios-
ity would be positively associated with positive religious coping and
medication adherence, and be negatively associated with negativeFig. 1.Model 1: relationships between religiosity, religious coping, and medication adherence
medication adherence included antiepileptic drug serum level and Medication Adherence Rep
in the model. *p b 0.001.religious coping; positive/negative religious coping would be positively/
negatively associated with medication adherence; positive and negative
religious copings would mediate the association between religiosity and
medication adherence.Model 2 (Fig. 2) hypothesized thatmedication ad-
herence would be positively associated with QoL and that positive and
negative religious coping together with medication adherence would
mediate the relationship between religiosity and QoL.
2. Methods
2.1. Participants
From 2015 to 2016, PWE were prospectively recruited from four
neurology clinics in the cities of Tehran and Qazvin. Participants were
included if they (a) were 18 years old or more, (b) had a diagnosis for
epilepsy identiﬁed by the International League Against Epilepsy criteria
[29]; and (c) had been prescribed antiepileptic drugs. Patients were ex-
cluded if they (a) were not able to provide consent or (b) had intellec-
tual disability or cognitive impartment (as assessed using the mini-
mental status examination: MMSE b 24 [30]). The study was approved
by the Ethics Committee of Qazvin University of Medical Sciences, and
all participants provided informed consent before enrolling in the study.
2.2. Measures
2.2.1. Religiosity: Duke University Religion Index (DUREL)
The DUREL, a ﬁve-item scale, was used to measure religiosity. The
ﬁve items were made up of three dimensions: intrinsic religiosity
(3 items), organizational religiosity (1 item), and nonorganizational re-
ligiosity (1 item). All items are rated on a ﬁve-point Likert scale [31]. As
suggested by the developers, the three dimensions should not be
summed to prevent effects canceling out each other [32]. Therefore,
using latent construct to measure the religiosity seems most appropri-
ate. In addition, the DUREL has been translated into Persian for use in
Iranian populations using the standard translation process, cognitive
debrieﬁng, and psychometric testing. The internal consistency is high
(α= 0.87 and 0.92), the test–retest reliability is excellent (intraclass
correlation coefﬁcient = 0.96 to 0.99), and the concurrent validity is
based on strong high correlations with the Santa Clara Strength of Reli-
gious Faith Questionnaire (r= 0.62 to 0.79) [33].
2.2.2. Religious coping: Brief Religious Coping Scale (Brief RCOPE)
The 14-item brief RCOPE measures positive (7 items) and negative
religious coping (7 items). Positive religious coping emphasizes connec-
tionswith a transcendent force and belief in a benevolent higher power;. Religiosity was composed of intrinsic, organizational, and nonorganizational religiosity;
ort Scale (MARS) score. Age, gender, duration of illness, and education were adjusted for
Fig. 2. Model 2: relationships between religiosity, religious coping, medication adherence, and quality of life (QoL). Religiosity was composed of intrinsic, organizational, and
nonorganizational religiosity; medication adherence included antiepileptic drug serum level and Medication Adherence Report Scale (MARS) score; QoL was measured using the
Quality of Life in Epilepsy. Age, gender, duration of illness, and education were adjusted for in the model. *p b 0.05; **p b 0.01; ***p b 0.001.
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doubting, and negative reappraisals of the divine [34,35]. Examples of
items on the positive religious coping subscale include “Looked for a
stronger connection with God” and “Sought God's love”. Sample items on
the negative religious coping subscale include “Wondered whether be
abandoned by God” and “Felt punished by God because of the lack of
devotion” [34]. All items are listed in Table 1.2.2.3. Medication adherence
Medication adherence was assessed using the ﬁve-item Medication
Adherence Report Scale (MARS-5); in addition, antiepileptic drug
serum levels were measured. The MARS-5 contains ﬁve items that ask
about medication adherence, all rated on a ﬁve-point Likert scale. A
higher score indicates better medication adherence. The MARS-5 has
satisfactory internal consistency (α= 0.78) [36] and concurrent valid-
ity (r = 0.50 with adherence ratings by healthcare providers) [37].
Although the psychometric properties of the MARS-5 Persian version
have not been examined previously, its linguistic validity has been dem-
onstrated [38].
Before participants took their next dose of drug (i.e., AEDs), blood
samples were obtained to determine antiepileptic drug serum levels
using a microparticle enzyme immunoassay (Abbott Axsym®, Abbott
Laboratories, Abbott Park, IL, USA), align with suggested procedure
[39]. Based on the recommendations [40], we classiﬁed all the data
into three categories: below, within, or above the therapeutic range.Table 1
Items in Brief Religious Coping Scale (Brief RCOPE).
Item
1. Looked for a stronger connection with God
2. Sought God's love and care
3. Sought help from God in letting go of my anger
4. Tried to put my plans into action together with God
5. Tried to see how God might be trying to strengthen me in this situation
6. Asked forgiveness for my sins
7. Focused on religion to stop worrying about my problems
8. Wondered whether God had abandoned me
9. Felt punished by God for my lack of devotion
10. Wondered what I did for God to punish me
11. Questioned God's love for me
12. Wondered whether my church had abandoned me
13. Decided the devil made this happen
14. Questioned the power of God2.2.4. Quality of life: Quality of Life in Epilepsy (QOLIE-31)
The QOLIE-31, a 31-item questionnaire, was used to assess the QoL.
Of the 31 items, one item is rated using a visual analogue scale, a second
item is assessed using a “face” scale, and the other 29 items are rated on
Likert-type scales (from 4 to 6 points). Except for the item on visual an-
alogue scale, the items make up the following seven domains: seizure
worry (5 items), cognitive function (6 items), energy/fatigue (4 items),
emotional well-being (5 items), social function (5 items), medication ef-
fects (3 items), and overall QoL (2 items). According to the developers
[41] and the scoring manual [42], all seven domains can be transformed
into a 0–100 scale with higher scores indicating better QoL. An overall
QoL score can then be computed based on the transformed domain
scores. The original English version of QOLIE-31 has acceptable psycho-
metric properties (test–retest reliability, r=0.64 to 0.89; internal consis-
tency,α=0.77 to 0.93) [42], and the Persian version has been validated
in Iran (test–retest reliability, r= 0.68; internal consistency, α= 0.90)
[43].
2.3. Procedure
Two trained research assistants screened patients for eligibility.
Eligible patients were asked to attend a short education session on
study aims and complete informed consent in a private clinic room. Of
922 approached patients, 812 (88%) participated in the education ses-
sion. Fifty-two patients did not sign the informed consent form and
were excluded from the study. Therefore, we analyzed the data of the
retained 760 PWE. After signing the consent form, participants were
asked to complete the religiosity scale and a sociodemographicmeasure
(baseline assessment). Participants completed the measure of religious
coping (brief RCOPE) at one month after the baseline assessment. Two
months after the baseline assessment, participants were asked to com-
plete the self-reported measure of medication adherence (MARS-5).
The objective measure of AED adherence was assessed on the same
day from blood samples. Twelvemonths after baseline assessment, par-
ticipants were asked to complete the QoL measure (QOLIE-31).
2.4. Data analysis
All the demographics and clinical characteristics were analyzed
using mean (SD) for continuous variables and n (%) for categorical var-
iables. We used structural equation modeling (SEM) to examine our
proposed models. It is a statistical analysis that includes two major
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ings and a structural component that estimates the path coefﬁcients
(i.e., the regression coefﬁcients) and correlations (similar to Pearson
correlation) [44]. Therefore, based on SEM, we can simultaneously ob-
tain different statistical values, including factor loading, R2, and path
and correlation coefﬁcients.
In our proposed models, Model 1 (Fig. 1) examined the associations
among religiosity, positive and negative religious copings, and medica-
tion adherence; Model 2 (Fig. 2) examined the associations between
QoL and the four aforementioned factors. To further examine the asso-
ciation between religiosity and QoL, Model 3 (Fig. 3) based on Model 2
was constructed. All models controlled the demographics of age,
gender, duration of illness, years of education. In addition, religiosity
(included intrinsic, organizational, and nonorganizational religiosity)
and medication adherence (included MARS-5 score and AED serum
levels)were constructed as latent variables. Directional instead of recip-
rocal associations were assumed in the twomodels because we collect-
ed the data in a certain sequence across time (religiosity at baseline;
religious coping at one-month follow-up; medication adherence at
two-month follow-up; QoL at twelve-month follow-up). These direc-
tional effects were based on the literature [16,17,19,20,25,26]. More-
over, we assessed constructs at different follow-up times, assuming
that QoL changes more slowly in people with chronic epilepsy with re-
ligious coping and medication adherence preceding those changes. The
literature suggests that religiosity leads to religious coping, which leads
to medication adherence, which leads to QoL [16,17,19,20,25,26].
Therefore, we believe that the time sequence of assessments during
follow-up was appropriate.
The measurement part of the SEM models (i.e., whether the three
domain scores loaded on the religiosity domain; whether MARS-5 and
serum level loaded on the medication adherence domain) was exam-
ined in addition to the structural part (i.e., the paths among factors) of
the models. Speciﬁcally, we hypothesized that religiosity and religious
coping were directly associated with medication adherence, and medi-
cation adherence and religious coping were directly associated with
QoL. We also hypothesized that positive and negative religious coping
were mediators in the relationship between religiosity and medication
adherence, and that both religious coping and medication adherence
were mediators in the relationship between religiosity and QoL.
Both SEM models were estimated using the maximum likelihood
method, and the missing values were treated using the full informationFig. 3.Model 3: religiosity measured by intrinsic, organizational, and nonorganizational indic
Adherence Report Scale (MARS) score; and quality of life measured using the Quality of Life i
model. *p b 0.05; **p b 0.01; ***p b 0.001.maximum likelihood estimator. Before testing the path coefﬁcient and
mediated effects, we used four indices to determine acceptable model
ﬁt for both models: comparative ﬁt index (CFI) and Tucker–Lewis
index (TLI) were set at 0.9 or above; root mean square of error approx-
imation (RMSEA) and standardized root mean square residual were set
at 0.08 or below [45–47]. After ensuringmodel ﬁt, we examinedwheth-
er the measurement part of both models were acceptable; acceptable
measurement should have all factor loadings N0.3. Finally, we used
Sobel tests to test the signiﬁcance level of each of the mediated effects
[48].
Data were analyzed using SPSS 23.0 (for descriptive analyses of de-
mographics and clinical characteristics) and R software with Lavaan
package (for model testing and mediated effects of the two SEM
models) [49].
3. Results
Table 2 demonstrates the characteristics of participants (n = 760),
including religiosity, religious coping, medication adherence, and QoL.
Participants were relatively young (mean age = 36.19; SD = 13.13).
Nearly half (45.5%) were male, and most were currently married
(76.2%). Mean duration of illness was 6.86 years (SD = 4.54). The
most common diagnosis was symptomatic partial epilepsy (45.7%),
followed by idiopathic generalized epilepsy (30.7%), and cryptogenic
partial epilepsy (23.7%). At the two-month follow-up, slightly more
than half of the participants had AED serum levels in the recommended
therapeutic range (52.6%).
All proposedmodels (Figs. 1–3) had acceptable ﬁt, except for the sig-
niﬁcant χ2. InModel 1,ﬁt indiceswere CFI= 0.95, TLI= 0.93, RMSEA=
0.038, and SRMR=0.034; inModel 2, theywere CFI= 0.95, TLI= 0.93,
RMSEA = 0.037, and SRMR = 0.034; and in Model 3, they were CFI =
0.95, TLI = 0.92, RMSEA = 0.038, and SRMR = 0.034. With regard to
the measurement part of both models, intrinsic (factor loading =
0.71), organizational (factor loading= 0.72), and nonorganizational re-
ligiosity (factor loading= 0.36) loaded strongly on the latent construct
of religiosity (all p-values b0.001);MARS-5 (factor loading= 0.87) and
antiepileptic serum level (factor loading= 0.37) also loaded acceptably
on the latent construct of medication adherence (both p-values
b0.001). In terms of the structural part of both models, all paths were
signiﬁcant except for the path between religiosity and positive religious
coping (standardized coefﬁcient= 0.069 and p=0.12 in bothmodels).ators; medication adherence assessed by antiepileptic drug serum level and Medication
n Epilepsy Scale. Age, gender, duration of illness, and education were adjusted for in the
Table 2
Participants' characteristics.
Characteristics n (%) or M (SD)
Baseline
Age (year) 36.19 (13.13)
Gender (male) 346 (45.5%)
Years of education 8.88 (5.11)
Marital status
Single 162 (21.3%)
Married 579 (76.2%)
Widowed 18 (2.4%)
Missing 1 (0.1%)
Duration of illness (year) 6.86 (4.54)
Type of epilepsy
Generalized 233 (30.7%)
Focal 527 (69.3%)
Age at the seizure onset 29.33 (12.83)
Surgical intervention (yes) 160 (21.1%)
Type of AED
Monotherapy 343 (45.1%)
Polytherapy 417 (54.9%)
MMSE 28.0 (2.2)
Type of lesionsa
DNET 30 (16.7%)
Ganglioglioma 23 (12.8%)
traumatic brain injury 60 (33.3%)
Acute cerebrovascular accident 22 (12.2%)
Unknown 45 (25.0%)
Religiosity
Intrinsic 9.14 (4.87)
Organizational 3.75 (1.88)
Non-organizational 3.91 (2.00)
One month after baseline
Positive religious coping 18.05 (7.51)
Negative religious coping 13.33 (7.31)
Two months after baseline
Medication Adherence Report Scale 13.46 (6.52)
Antiepileptic drug serum level
Below therapeutic range 360 (47.4%)
Within therapeutic range 298 (39.2%)
Above therapeutic range 102 (13.4%)
One year after baseline
Quality of Life in Epilepsy 68.82 (20.34)
DNET = Dysembryoplastic neuroepithelial tumor; MMSE = mini-mental status
examination.
a With missing values.
Table 3
Mediated effects in the relationship between religiosity andmedication adherence (Model
1), and between religiosity and quality of life (Model 2).
Mediator(s) Coefﬁcient (SE)/standardized coefﬁcient
Model 1 Model 2
Positive religious coping 0.466 (0.310)/0.020⁎⁎ 0.190 (0.129)/0.013
Negative religious coping −1.387 (0.392)/−0.060⁎⁎⁎ −0.296 (0.157)/−0.019#
Medication adherence – 0.788 (0.304)/0.052⁎
Positive religious coping
and medication adherence
– 0.073 (0.053)/0.005
Negative religious coping
and medication adherence
– 0.230 (0.097)/0.015⁎
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001.
# p = 0.06.
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and both religiosity and medication adherence; all other associations
were positive.
Religiosity, positive religious coping, and negative religious coping
together explained a substantial proportion of variance of medication
adherence (48.5% in Model 1 and 48.9% inModel 2). The explained var-
iance for QoL, however, was only modest in Model 2 (11.6%). Model 3
was similar to Model 2, although religiosity was not signiﬁcantly corre-
lated with QoL in that model (Fig. 3). In addition to the direct effects
shown in Models 1 and 2, Sobel tests revealed several signiﬁcant
mediated effects (Table 3) as follows: negative religious coping in the
relationship between religiosity and medication adherence (standard-
ized coefﬁcient =−0.060; p b 0.001); medication adherence in the re-
lationship between religiosity and QoL (standardized coefﬁcient =
0.052; p = 0.01); and negative religious coping together with medica-
tion adherence in the relationship between religiosity and QoL
(standardized coefﬁcient = 0.015; p = 0.02).
4. Discussion
We found that religiosity directly correlated with negative religious
coping and medication adherence, and indirectly correlated with med-
ication adherence through negative religious coping. Both positive
and negative religious copings directly correlated with medicationadherence and QoL. Thus, religiosity was indirectly correlated with
QoL through medication adherence and negative religious coping.
The ﬁnding of positive relationship between religiosity and medica-
tion adherence supported our hypothesis and is consistent with studies
on people with HIV/AIDS [16,17]. However, the results here on religious
coping andmedication adherence are inconsistent with studies on peo-
ple with inﬂammatory bowel disease [20]. Although results from both
Freitas et al. [20] and us indicate that negative religious coping has a
negative relationship with medication adherence, the signiﬁcant rela-
tionship found between positive religious coping and medication ad-
herence contrasts with the nonsigniﬁcant ﬁnding reported by Freitas
et al. [20].
Three possible reasons may explain differences between the results
of Freitas et al. [20] and ours. First, the populations were different.
Freitas et al. [20] examined a Brazilian sample, while we studied an
Iranian sample. Because these ethnic groups may vary in their religious
beliefs, the effects of religious coping may differ as well. Second, Freitas
et al. [20] adopted a cross-sectional design to test the relationship be-
tween religious coping and medication adherence, while we collected
the information on religious coping (one month after baseline) and
medication adherence (two months after baseline) at different time
points. It is possible that negative religious coping may have earlier ef-
fects than positive religious coping on medication adherence does.
Third, Freitas et al. [20] only used a subjective report of medication ad-
herence, whereas we used both subjective and objective measures. The
different adherence measures, then, could account for the different
ﬁndings.
Future studies are needed to determine the validity of the specula-
tions. However, the relationship between negative religious coping
and medication adherence in both the present study and Freitas et al.
[20] suggests that health professionals in epileptic care should consider
addressing negative religious coping among PWE to increase their med-
ication adherence. In addition, some may question whether different
measures of AED adherence (i.e., MARS-5 vs. AED serum levels) may
vary in their correlation with religiosity, positive religious coping, and
negative religious coping. Given that this was not the primary purpose
of this study, we constructed another SEM model that did not combine
MARS-5 and serum levels as a latent construct to address this. Those re-
sults showed thatMARS-5 (R2=0.31), comparedwith AED serum level
(R2 = 0.07), had a stronger correlation with religiosity, positive reli-
gious coping, and negative religious coping. Future studies may wish
to replicate these ﬁndings.
The relationship between religiosity and QoL shown inModel 2 sug-
gests that these two factors are only weakly correlated, and a similar
ﬁnding has been found in patients undergoing hemodialysis in Iran
[50]. Theweak andmediated associations help to explain why some in-
vestigators found a signiﬁcant relationship between religiosity and QoL
[27], while others have not [28]. We found that religiosity was associat-
ed with QoL only whenmediated bymedication adherence. In addition,
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tion adherence; B = 0.015 through negative religious coping and med-
ication adherence). Indeed, the explained variance for QoL in the entire
model was quite low (11.6%). The direct relationship between religious
coping and QoL and that between medication adherence and QoL
are consistent with previous studies on PWE [25–28]. The nonsigniﬁ-
cant correlation between religiosity and QoL indicated in Model 3 sug-
gests that religiosity might not have a direct association with QoL.
Instead, religiosity is likely related with QoL through other mediators
(e.g., religious coping and medication adherence).
Based on our ﬁndings, we propose two recommendations for health
professionals when providing epileptic care. First, we recommend that
providers encourage PWE to use positive religious coping. Among
PWE who are using negative religious coping, health professionals
should consider referring them to pastoral care providers (chaplains,
pastoral counselors, and other trained clergy) to address their religious
coping struggles [51]. Second, we recommend that integrating patients'
religious beliefs into counselingmay enhance its effectiveness. Indeed, a
meta-analysis has conﬁrmed the positive effects of religious interven-
tions on both biological and psychological outcomes for oncology pa-
tients [52]. We believed that such interventions might have similar
effects in PWE.
4.1. Limitations
There are several limitations to the study. First, it is unclear whether
these results can be generalized to other ethnicities because of their
varying religious beliefs. For example, all of our participants were
Muslim, and it is unclear whether the effects of religious beliefs in
Muslim are similar to those with other religion beliefs (e.g., Buddhists
and Christians). Second, although we applied a longitudinal design to
investigate the relationships among religiosity, religious coping, medi-
cation adherence, and QoL for PWE, this is essentially a cross-sectional
analysis; and we did not control for outcomes at baseline. That is, we
did not measure baseline medication adherence and QoL. Therefore,
we cannot conclude that changes in religious coping affect change of
medication adherence or QoL. Third, our measures on medication ad-
herence may be affected by (1) previous studies showing that MARS-5
correlated poorly withmedication reﬁlls [53], and (2) half of our partic-
ipants had low AED serum levels; such low levels could be due to inad-
equate prescribing, time of testing (hours postdose), or poor adherence.
Fourth,we did not control formood or seizure frequency, two poten-
tially important confounders in our proposedmodel [23,24,54].We rec-
ommend that future studies that seek to replicate our ﬁndings control
for both mood and seizure frequency. Mood, anxiety, or other psycho-
logical symptoms may inﬂuence and interact with general coping and
QoL. Furthermore, seizure frequency may be correlated with drug-
resistance and medication adherence, and the AED regimen may affect
cognitive functions and daily activities. Given that AED treatment
consisted of 45.1% monotherapy and 54.9% polytherapy, we speculate
that our sample was evenly distributed between mild and severe
epilepsy.
Fifth, incomplete information on brain lesion, lesion location and
laterality in nearly half of the sample, and such factors may affect cogni-
tion and coping behavior, particularly if the lesion involves the frontal or
mesial temporal lobe or other limbic structures. Future studies
attempting to replicate our ﬁndings should collect such information.
Sixth, the measures used in this study, such as the RCOPE and the
MARS-5 (our primary measure of drug adherence) may also have limi-
tations. The RCOPE likely has some overlap with the DUREL, in that
thosewho are more religious are likely to use religion in coping. The re-
liability of MARS-5 (our primarymeasure of drug adherence), in turn, is
notwell-established. Lastly, we did not collect information on how PWE
think about their bodies. Some pious people may wish to keep their
bodies pure and free from medication, and some may believe that sei-
zures are their destiny (a concept that is very important in Islam).Therefore, religiosity may result in both poorer adherence and better
adherence, issues that future psychological and philosophical studies
will need to address.
4.2. Conclusion
In conclusion, the present ﬁndings suggest that religiosity and reli-
gious coping may be determinants of medication adherence and QoL
in PWE. Higher level of religiosity may lead to less negative religious
coping, and the less use of negative religious coping may help to in-
crease medication adherence. Since higher positive religious coping
was associatedwith greatermedication adherence, health professionals
may consider asking PWE if religion is important to them and how they
use it to cope with their epilepsy. If religion is important to them and
they use it to cope, then encouraging positive forms of religious coping
may be considered. Among those who are using negative religious cop-
ing, referral to religious professionalswhoare trained on how to address
these issues (pastoral counselors, chaplains) may be warranted.
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